Skip to Main Content

Genomics, Genetics, & Epigenetics

The Genomics, Genetics, and Epigenetics (GGE) Program is a preeminent national and international hub for groundbreaking cancer genomic and genetic/epigenetic research that makes field-changing discoveries, develops impactful novel analytical tools, and translates these discoveries into new therapies and diagnostic tests.

In collaboration with the program leaders — Lajos Pusztai, MD, DPhil, Jeffrey Townsend PhD, and Qin Yan, PhD — members of the GGE program study gene alterations in cancer with the goal of translating this knowledge into new drugs, novel therapeutic strategies, and novel diagnostic tests.

  • Studies

    GGE studies include:

    • The discovery of mutations in genes and DNA that cause cancer
    • Analysis of genomic changes and their functional consequences on gene expression
    • Characterization of mechanisms that control protein production from genes
    • Epigenetics
    • Protein structure
    • Analysis of large-scale genomic data
  • Goals

    The goals of the GGE Program are to:

    1. Identify and characterize the function of genetic alterations and epigenetic changes that contribute to cancer development and progression.
    2. Develop new analytical tools, data resources, and novel laboratory models that enable better characterization and understanding of the cancer genome.
    3. Translate genomic observations into clinically useful diagnostic and prognostic tests, and develop new therapies that exploit genetic and epigenetic alterations in cancer.